SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma

Table 3 CpGs with methylation across the patients with TCGA–LIHC

CpG	Chromosome	Start	End	UCSC_RefGene_Group	Relation_to_UCSC_CpG_Island	Overall Survival (beta-value) Median Cutoff (50%)
CpG	Chromosome	Start	End	UCSC_RefGene_Group	Relation_to_UCSC_CpG_Island	HR	95% CI	p value
cg20426713	chr1	84297655	84297656	TSS1500	N_Shore	0.86	0.61–1.21	0.386
cg11555919	chr1	84298249	84298250	TSS200	N_Shore	0.8	0.57–1.12	0.196
cg24002839	chr1	84298595	84298596	Body	Island	0.87	0.62–1.23	0.437
cg16026299	chr1	84298692	84298693	Body	Island	1.32	0.94–1.85	0.112
cg15103960	chr1	84299021	84299022	Body	Island	0.71	0.51–1	0.052
cg02041547	chr1	84299222	84299223	Body	Island	0.46	0.32–0.64	< 0.001
cg23694882	chr1	84300841	84300842	TSS1500;Body	S_Shore	1.52	1.08–2.14	0.016
cg17142950	chr1	84301099	84301100	TSS1500;Body	S_Shore	1.04	0.74–1.46	0.838
cg19869443	chr1	84301138	84301139	TSS1500;Body	S_Shore	0.94	0.67–1.33	0.731
cg23086720	chr1	84301641	84301642	1stExon;TSS1500;5'UTR;Body	S_Shelf	0.51	0.36–0.72	< 0.001
cg20466954	chr1	84302676	84302677	1stExon;5'UTR;Body	S_Shelf	0.93	0.66–1.31	0.691
cg13305246	chr1	84303019	84303020	5'UTR;Body	S_Shelf	1.05	0.75–1.48	0.762
cg15089272	chr1	84329844	84329845	Body	OpenSea	1.5	1.07–2.12	0.019
cg22529952	chr1	84347529	84347530	Body	OpenSea	1.27	0.9–1.79	0.171
cg23925111	chr1	84350246	84350247	3'UTR	OpenSea	1.62	1.15–2.27	0.006

CpG (CpG ID), UCSC_RefGene_Name (gene name, based on UCSC annotations); UCSC_RefGene_Group (gene region, based on UCSC annotations); Relation_to_UCSC_CpG_Island (island region, based on UCSC annotations); Regulatory_Feature_Group (type of regulatory region, based on EPIC manifest annotations). Bold font indicates statistical significance

ISSN: 2047-783X